Pulse Biosciences Earnings Estimate

PLSE Stock  USD 13.55  0.77  5.38%   
The next projected EPS of Pulse Biosciences is estimated to be -0.285 with future projections ranging from a low of -0.285 to a high of -0.285. Pulse Biosciences' most recent 12-month trailing earnings per share (EPS TTM) is at -1.14. Please be aware that the consensus of earnings estimates for Pulse Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Pulse Biosciences is projected to generate -0.285 in earnings per share on the 31st of December 2025. Pulse Biosciences earnings estimates show analyst consensus about projected Pulse Biosciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Pulse Biosciences' historical volatility. Many public companies, such as Pulse Biosciences, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Pulse Biosciences' earnings estimates, investors can diagnose different trends across Pulse Biosciences' analyst sentiment over time as well as compare current estimates against different timeframes. As of January 29, 2026, Gross Profit is expected to decline to about (1.1 M). In addition to that, Pretax Profit Margin is expected to decline to -100.92Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.

Pulse Biosciences Earnings Estimation Breakdown

The calculation of Pulse Biosciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Pulse Biosciences is estimated to be -0.285 with the future projection ranging from a low of -0.285 to a high of -0.285. Please be aware that this consensus of annual earnings estimates for Pulse Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.31
-0.28
Lowest
Expected EPS
-0.285
-0.28
Highest

Pulse Biosciences Earnings Projection Consensus

Suppose the current estimates of Pulse Biosciences' value are higher than the current market price of the Pulse Biosciences stock. In this case, investors may conclude that Pulse Biosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Pulse Biosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
176.82%
-0.3124
-0.285
-1.14

Pulse Biosciences Earnings per Share Projection vs Actual

Actual Earning per Share of Pulse Biosciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Pulse Biosciences predict the company's earnings will be in the future. The higher the earnings per share of Pulse Biosciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Pulse Biosciences Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Pulse Biosciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Pulse Biosciences should always be considered in relation to other companies to make a more educated investment decision.

Pulse Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Pulse Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-10-29
2025-09-30-0.31-0.290.02
2025-08-12
2025-06-30-0.26-0.28-0.02
2025-03-26
2024-12-31-0.24-0.3124-0.072430 
2024-10-30
2024-09-30-0.24-0.20760.032413 
2024-08-19
2024-06-30-0.2-0.19919.0E-4
2024-05-07
2024-03-31-0.24-0.18370.056323 
2024-03-28
2023-12-31-0.24-0.21670.0233
2023-11-13
2023-09-30-0.22-0.190.0313 
2023-08-10
2023-06-30-0.22-0.220.0
2023-05-11
2023-03-31-0.22-0.26-0.0418 
2023-03-30
2022-12-31-0.24-0.25-0.01
2022-11-10
2022-09-30-0.45-0.49-0.04
2022-08-10
2022-06-30-0.4-0.44-0.0410 
2022-05-11
2022-03-31-0.52-0.58-0.0611 
2022-03-31
2021-12-31-0.51-0.52-0.01
2021-11-15
2021-09-30-0.53-0.480.05
2021-08-09
2021-06-30-0.69-0.580.1115 
2021-05-10
2021-03-31-0.49-0.71-0.2244 
2021-02-22
2020-12-31-0.45-0.54-0.0920 
2020-11-09
2020-09-30-0.44-0.51-0.0715 
2020-08-10
2020-06-30-0.5-0.53-0.03
2020-05-11
2020-03-31-0.47-0.57-0.121 
2020-03-16
2019-12-31-0.61-0.66-0.05
2019-11-07
2019-09-30-0.61-0.570.04
2019-08-08
2019-06-30-0.51-0.55-0.04
2019-04-30
2019-03-31-0.44-0.49-0.0511 
2019-02-07
2018-12-31-0.51-0.510.0

About Pulse Biosciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pulse Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Pulse Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Pulse Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-351.4 M-333.9 M
Retained Earnings Total Equity-155.3 M-147.5 M
Earnings Yield(0.06)(0.06)
Price Earnings Ratio(17.08)(17.93)
Price Earnings To Growth Ratio(4.80)(4.56)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Health Care Equipment & Supplies sector continue expanding? Could Pulse diversify its offerings? Factors like these will boost the valuation of Pulse Biosciences. Anticipated expansion of Pulse directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulse Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.14)
Revenue Per Share
0.001
Return On Assets
(0.49)
Return On Equity
(0.87)
Investors evaluate Pulse Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Pulse Biosciences' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Pulse Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Pulse Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulse Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Pulse Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.